The global airway management devices market is poised for steady growth, driven by the increasing prevalence of chronic respiratory diseases, rising demand for advanced critical care solutions, and continuous technological innovations in respiratory healthcare. Valued at US$ 1.1 Bn in 2021, the market is projected to expand at a CAGR of 7.7% from 2022 to 2031, reaching US$ 2.3 Bn by the end of 2031.

Airway management devices play a vital role in ensuring an open airway for patients requiring respiratory support during surgeries, emergency care, intensive care treatment, and trauma management. The growing incidence of asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis, and other respiratory disorders has significantly increased the demand for these life-saving medical devices. Furthermore, the COVID-19 pandemic highlighted the importance of maintaining adequate respiratory care infrastructure, encouraging hospitals and healthcare providers worldwide to strengthen their inventories of ventilators, airway management equipment, and critical care devices.

One of the primary factors fueling market expansion is the rising global burden of chronic respiratory diseases. According to the World Health Organization (WHO), more than 65 million people were living with COPD in 2019, while approximately 3 million deaths were attributed to the disease, making it the third leading cause of death worldwide. Asthma affects over 262 million people globally, while tuberculosis and lung cancer continue to account for millions of new cases and fatalities every year. Increasing exposure to air pollution, tobacco smoke, occupational hazards, and unhealthy lifestyles has further accelerated the prevalence of respiratory illnesses, creating sustained demand for airway management solutions.

Airway management devices include endotracheal tubes, tracheostomy tubes, laryngoscopes, resuscitators, positive airway pressure systems, and oropharyngeal airways. These devices are extensively utilized in operating rooms, intensive care units (ICUs), emergency departments, ambulances, and outpatient settings to maintain airway patency, facilitate ventilation, and administer anesthesia safely. Continuous improvements in device design are enhancing patient safety, reducing procedural complications, and improving clinical outcomes.

Technological innovation remains a major growth catalyst for the market. Manufacturers are introducing advanced airway management systems with enhanced visualization, improved ergonomics, and minimally invasive features. Video laryngoscopes, disposable airway devices, and technologically advanced infraglottic devices have gained widespread acceptance among healthcare professionals due to their ability to simplify difficult airway procedures and increase procedural success rates. Portable and user-friendly airway management equipment is also witnessing increased adoption in emergency medical services and home healthcare environments.

Among product categories, infraglottic devices are expected to maintain the largest market share throughout the forecast period. Products such as endotracheal tubes and tracheostomy tubes are widely used for airway stabilization during surgeries, emergency interventions, and critical care treatment. Their increasing utilization in hospitals, coupled with ongoing product innovations, is supporting segment growth, particularly across North America and Europe.

The growing geriatric population represents another major driver for the airway management devices market. Aging individuals are more susceptible to respiratory disorders due to weakened immune systems and age-related decline in lung function. As life expectancy continues to rise globally, healthcare systems are witnessing a growing number of elderly patients requiring respiratory support during surgeries, chronic disease management, and intensive care. Additionally, increasing incidences of preterm births and neonatal respiratory complications have expanded the demand for specialized pediatric airway management devices, further broadening the market landscape.

Operating rooms (ORs) remain the largest end-user segment for airway management devices. Airway management equipment is essential during surgical procedures for maintaining ventilation, oxygenation, and safe anesthesia administration. The increasing number of surgical interventions worldwide, supported by expanding healthcare infrastructure in emerging economies, continues to drive demand within this segment. Intensive care units also represent a rapidly growing application area due to rising admissions of critically ill patients requiring mechanical ventilation and respiratory support.

Geographically, North America accounted for the largest share of the global airway management devices market in 2021. The region benefits from advanced healthcare infrastructure, high healthcare expenditure, widespread adoption of technologically advanced medical devices, and a growing elderly population. Continuous product innovation and strong presence of leading medical device manufacturers further strengthen North America's market position.

Europe is expected to witness significant growth owing to favorable government healthcare initiatives, increasing awareness regarding respiratory care, and modernization of hospital infrastructure. Meanwhile, the Asia Pacific region is projected to register the fastest growth during the forecast period. Rapid improvements in healthcare infrastructure, expanding healthcare access, rising disposable incomes, growing patient populations, and increasing investments in medical technology are fueling market expansion across countries such as China, India, and Japan.

Despite favorable growth prospects, the market faces several challenges. The high cost of advanced airway management devices, limited accessibility in low-income regions, and pricing pressure within public healthcare systems may restrain market growth. Consequently, manufacturers are increasingly focusing on developing cost-effective, easy-to-use, and portable airway management solutions to improve accessibility while maintaining clinical performance.

The competitive landscape remains consolidated, with leading companies investing heavily in research and development, product innovation, mergers, acquisitions, and strategic collaborations. Major players operating in the market include GE Healthcare, Medtronic plc, Koninklijke Philips N.V., Olympus Corporation, Smiths Medical, Karl Storz GmbH & Co. KG, Teleflex Incorporated, VYAIRE, Ambu A/S, and Medline Industries, Inc.

Recent strategic developments demonstrate the industry's commitment to innovation. Olympus Corporation expanded its respiratory product portfolio through the launch of advanced video rhino-laryngoscopes and HANAROSTENT esophageal stents. Royal Philips collaborated with the Consortium for Affordable Medical Technologies (CAMTech) to develop neonatal resuscitation devices aimed at reducing infant mortality. These initiatives highlight the industry's focus on improving patient outcomes through technological advancement.

Overall, the global airway management devices market is expected to maintain strong growth through 2031, supported by the increasing burden of respiratory diseases, expanding surgical procedures, technological innovations, and rising investments in healthcare infrastructure. Companies that prioritize affordable innovation, digital integration, and advanced respiratory care technologies will be well-positioned to capitalize on the growing global demand for airway management solutions.